Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants
Starting soon · Not applicable
Conditions studied: Healthy Participants
In brief
This clinical trial evaluates the postprandial glycaemic response to an Oral Nutritional Supplement (ONS), a Food for Special Medical Purposes (FSMP), in healthy adults. The study uses a crossover design comparing the ONS to the reference product glucose. Each participant will consume both test and reference products on three separate occasions each, overall on six test days.
Key facts
- Study ID
- NCT07479251
- Run by
- Fresenius Kabi
- People needed
- 30
- Starts
- 2026-03-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-03-23
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Aged ≥18 and ≤60 years, adult healthy Caucasian or Chinese participants
- Stable body weight within the Body Mass Index between 18.5 kg/m2 and 27.9 kg/m2 (inclusive)
- Glycated hemoglobin < 6%/< 42 mmol/mol
You may not qualify if…
- Pregnant or lactating,
- Body fat percentage exceeding 30%,
- Known history of metabolic diseases or diabetes mellitus,
- Major medical or surgical event requiring hospitalization within the preceding 3 months
- Medical condition(s) or medication(s) or herbal effects known to affect glucose regulation, tolerance or appetite and/or which influence digestion and absorption of nutrients (excluding oral contraceptives),
- Use of steroids, protease inhibitors, amphetamines or antipsychotics
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.